Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
NexGel Inc Warrant (NXGLW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: NXGLW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -91.96% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.52 | 52 Weeks Range 0.22 - 0.95 | Updated Date 05/15/2025 |
52 Weeks Range 0.22 - 0.95 | Updated Date 05/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.39 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -30.7% | Operating Margin (TTM) -27.69% |
Management Effectiveness
Return on Assets (TTM) -20.77% | Return on Equity (TTM) -60.08% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 6447417 |
Shares Outstanding - | Shares Floating 6447417 | ||
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
NexGel Inc Warrant
Company Overview
History and Background
NexGel, Inc. is a hydrogel technology company. It focuses on developing, manufacturing, and commercializing high water content, cross-linked polymer hydrogels. The warrants were issued in connection with a financing round and represent the right to purchase shares of NexGel common stock under specified conditions.
Core Business Areas
- Hydrogel Technology: Developing and manufacturing advanced hydrogels for various applications, including wound care and cosmetic patches.
Leadership and Structure
Information on specific leadership team members and the organizational structure is generally available on the NexGel Inc. website and SEC filings.
Top Products and Market Share
Key Offerings
- Wound Care Hydrogels: Hydrogels designed to promote healing and prevent infection in wounds. Market share data is difficult to determine precisely, but competitors include companies like Smith & Nephew (SNN), Molnlycke, and 3M (MMM).
- Cosmetic Patches: Hydrogel-based cosmetic patches for skincare applications. Competitors include Johnson & Johnson (JNJ), L'Oreal (OR.PA), and various private label manufacturers.
Market Dynamics
Industry Overview
The hydrogel market is growing, driven by increasing demand in healthcare, cosmetics, and other industries. Growth is fueled by innovations in hydrogel formulations and expanding applications.
Positioning
NexGel aims to compete by developing advanced hydrogels with unique properties and targeting niche markets. Their competitive advantage would hinge on technological differentiation and effective commercialization.
Total Addressable Market (TAM)
The global hydrogel market is estimated at several billion dollars and projected to grow significantly. NexGel's positioning within this TAM depends on its ability to capture market share in specific application areas.
Upturn SWOT Analysis
Strengths
- Proprietary hydrogel technology
- Potential for innovation in specific applications
- Focus on high-value niche markets
Weaknesses
- Limited financial resources
- Small market presence
- Dependence on specific technologies or applications
- Unclear commercialization strategy
Opportunities
- Expansion into new markets and applications
- Partnerships with larger companies
- Development of novel hydrogel formulations
- Increasing demand for advanced wound care and cosmetic products
Threats
- Competition from established players
- Technological obsolescence
- Regulatory hurdles
- Economic downturn affecting healthcare spending
Competitors and Market Share
Key Competitors
- SNN
- MMM
- JNJ
Competitive Landscape
NexGel's advantages depend on its proprietary technology and ability to target niche markets effectively. Disadvantages stem from its small size and limited resources compared to larger competitors.
Growth Trajectory and Initiatives
Historical Growth: Historical growth can be assessed from the company's financial reports.
Future Projections: Future growth projections depend on various factors, including market trends, competitive landscape, and the company's ability to execute its strategy. Analyst estimates, if available, would provide insights into these projections.
Recent Initiatives: Review company announcements and press releases to identify recent strategic initiatives.
Summary
NexGel, as reflected by the warrant, is a high-risk, high-reward investment. Success depends heavily on successful product development and commercialization in a competitive market. The company's small size and limited resources require careful management. Potential investors should carefully consider the company's growth prospects and the risks associated with its business model.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Website
- Industry Reports
- Financial News Sources
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Investment decisions should be based on individual risk tolerance and due diligence. Market share data is estimated and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About NexGel Inc Warrant
Exchange NASDAQ | Headquaters Langhorne, PA, United States | ||
IPO Launch date 2021-12-22 | CEO, President & Director Mr. Adam R. Levy | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 19 | Website https://nexgel.com |
Full time employees 19 | Website https://nexgel.com | ||
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.